The emerging economies such as Australia
and China are expected to provide a wide range of growth opportunities for
players in the market which is driven by their large and growing populations as
well as increase in the number of clinical trials and investments in the field
of personalized medicine in these countries.
Download PDF Brochure: @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=213334978
The growth of this market is driven by the
rising government investments in cell-based research, increasing incidence of
chronic and infectious diseases, a large number of oncology-related cell
therapy clinical trials, and increasing GMP certifications for cell therapy
production facilities.
The cell therapy technologies market is
projected to reach USD 5.6 billion by 2025 from USD 2.8 billion in 2020, at a
CAGR of 14.4% from 2020 to 2025.
“Consumables is expected to hold the
largest share of the cell therapy technologies market, by product in 2020.”
On the basis of product, the market is
segmented into consumables, equipment, and systems & software. The
consumables segment accounted for the largest share of the cell therapy
technologies market in 2019. Factors such as increasing investments by
companies to develop advanced products as well as government initiatives for
enhancing cell-based research are contributing to the growth of the cell
therapy consumables market.
“T-cells is expected to hold the largest
share of the cell therapy technologies market, in 2020.”
On the basis of cell type, the market is
segmented into T-cells, stem cells, and other cells. In 2019, T-cells accounted
for the largest share of the cell therapy technologies market. Favorable
government initiatives and the increasing demand for T-cell therapies are the
key factors driving the growth of this segment.
“Cell processing is expected to hold the
largest share of the cell therapy technologies market in 2020.”
On the basis of process, the market is
segmented into cell processing, cell preservation, distribution and handling,
and process monitoring and quality control. The cell processing segment dominated
the market in 2019. This segment is expected to grow at the highest CAGR during
the forecast period. The cell processing stage makes the highest use of cell
therapy instruments and media, especially during culture media processing. This
is the major factor responsible for the large share and high growth of this
segment.
“Biopharmaceutical & biotechnology
companies and CROs segment commanded the largest share of the cell therapy
technologies market in 2020.”
By end user, the cell therapy technologies market
is segmented into biopharmaceutical & biotechnology companies and CROs and
research institutes, and cell banks. Biopharmaceutical & biotechnology
companies and CROs dominate the market and are expected to grow at the highest
CAGR. The large share of this regional segment can primarily be attributed to
the high burden of chronic diseases and increasing R&D activities in the
pharmaceutical and biotechnology industries.
“North America commanded the largest
share of the cell therapy technologies market in 2020.”
On the basis of region, the cell therapy
technologies market is segmented into North America, Europe, Asia Pacific, and
the Rest of the World. In 2019, North America commanded the largest share of
the cell therapy technologies market. The large share of this market segment
can be attributed to the increasing incidence of CVD, increasing healthcare
expenditure, growing disposable income, growing healthcare awareness, and the
availability of technologically advanced devices in the region.
The major players operating in this market
are Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany). MaxCyte (US),
Danaher Corporation (US), and Becton, Dickinson and Company (US), Lonza Group
(Switzerland), Sartorius AG (Germany), Terumo BCT (US), Fresenius Medical Care
AG & Co. KGaA (Germany), Avantor, Inc. (US), Bio-Techne Corporation (US),
Corning Incorporated (US), FUJIFILM Irvine Scientific (US), MaxCyte (US), Werum
IT Solutions GmbH (Germany), RoosterBio Inc. (US), SIRION Biotech GmbH
(Germany), CellGenix GmbH (Germany), L7 Informatics, Inc. (US), Miltenyi Biotec
GmbH (Germany), STEMCELL Technologies (Canada), Hemasoft (US), MAK-SYSTEM (US),
OrganaBio, LLC (US), IxCells Biotechnology (China), and Wilson Wolf Corporation
(US).
Thermo Fisher Scientific (US)
Thermo Fisher was the largest player in the cell therapy technologies market in 2019. It has focused on expansion to maintain its position in the market and expand its product portfolio. For instance, in May 2020, Thermo Fisher Scientific expanded its capacity for viral vector development and manufacturing services with a new commercial manufacturing site in Plainville, Massachusetts.
Don’t miss out on business opportunities
in Cell Therapy Technologies Market. Speak to our analyst and gain crucial
industry insights that will help your business grow.